← All trials
NCT01790672
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 31, 2011
- Primary completion
- Sep 30, 2013
- Completion date
- Sep 30, 2013
- First posted
- Feb 13, 2013
- Last posted
- Jul 24, 2014
- Enrollment
- 40
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Institut Hospital del Mar d'Investigacions MèdiquesLead sponsor
- Fundacion IMIMCollaborator
- Institut Hospital del Mar d'Investigacions MèdiquesOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.